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Abstract
Background: Multiple prevention measures have the possibility of impacting HIV incidence in South Korea, including early
diagnosis, early treatment, and pre-exposure prophylaxis (PrEP). We investigated how each of these interventions could
impact the local HIV epidemic, especially among men who have sex with men (MSM), who have become the major risk
group in South Korea. A mathematical model was used to estimate the effects of each these interventions on the HIV
epidemic in South Korea over the next 40 years, as compared to the current situation.
Methods:We constructed a mathematical model of HIV infection among MSM in South Korea, dividing the MSM population
into seven groups, and simulated the effects of early antiretroviral therapy (ART), early diagnosis, PrEP, and combination
interventions on the incidence and prevalence of HIV infection, as compared to the current situation that would be
expected without any new prevention measures.
Results: Overall, the model suggested that the most effective prevention measure would be PrEP. Even though PrEP
effectiveness could be lessened by increased unsafe sex behavior, PrEP use was still more beneficial than the current
situation. In the model, early diagnosis of HIV infection was also effectively decreased HIV incidence. However, early ART did
not show considerable effectiveness. As expected, it would be most effective if all interventions (PrEP, early diagnosis and
early treatment) were implemented together.
Conclusions: This model suggests that PrEP and early diagnosis could be a very effective way to reduce HIV incidence in
South Korea among MSM.
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Introduction
The HIV epidemic has continued unabated in South Korea
since 1985 with 700–800 new infections every year.[1] The
epidemiology has changed over this time with a gradual shift from
transmissions from heterosexual to male homosexual exposures
being the greatest risk.[1,2] As a high-income country with a low
HIV prevalence (,0.03%) and the predominant transmission by
men who have sex with men (MSM), the implementation of
proper preventive measures using resources is important to
minimize the HIV epidemic. However, given the current lack of
change in HIV incidence but changing epidemiology, it is unclear
what preventive measures should be adopted to thwart the
epidemic. Mathematical models can be useful in helping guide
public health interventions or planning for future clinical research
trials, including HIV treatment. So far, some studies concerning
the effect of antiretroviral treatment (ART) on HIV incidence
using the mathematical analysis have been reported.[3–5] For
example, the possible effects of the widespread use of ART and
levels of unsafe sex on HIV incidence among MSM in San
Francisco and Sydney have been evaluated using mathematical
models.[4,5] Both of these models have informed public health
strategies and are relevant to the model developed in this study.
The introduction of ART into clinical practice has led to
dramatic reductions in morbidity and in mortality associated with
HIV infection.[6–8] Several studies have also observed the
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beneficial effects of ART for HIV-infected individuals on the
sexual transmission of the virus to their sexual partners.[9,10] For
HIV-uninfected high-risk individuals, ART has also been effective
in the prevention of HIV acquisition (iPrEX Trial).[10] Based on
the results of iPrEx study, the United States Centers for Disease
Control and Prevention (CDC) has developed guidelines on the
use of tenofovir and emcitritabine as pre-exposure prophylaxis
(PrEP) for MSM at high risk for HIV acquisition in the United
States.[11] However, it is not clear how the implementation of
PrEP impacts the incidence of HIV infection in "real life", non-
trial settings. Concerns have been raised as to whether PrEP could
result in increased risky sexual practices through behavioral
disinhibition. It is possible that individuals may feel biologically
protected and decide to abandon condom use, underscoring the
importance of implementing behavioral modification and encour-
aging continued condom use if PrEP is to be a successful public
health intervention.[12] In this study, using mathematical model,
we estimate the effects of a variety of prevention interventions,
including PrEP, on the HIV incidence and prevalence among
MSM in South Korea based on best available data and compared
to the current situation and trends.
Methods
The model and the parameters
We constructed a mathematical model of HIV infection among
MSM population in South Korea (Fig. 1 and Fig. S1). The model
aimed to evaluate the effect of preventive interventions on the time
trends of the incidence and prevalence of HIV infection in MSM
population of South Korea. The model divided the MSM
population into seven groups: uninfected MSM (X); HIV-infected
MSM undiagnosed (Y1); HIV-infected MSM diagnosed without
treatment (Y2); HIV-infected MSM with ART failure (Y3); HIV-
infected MSM with successful ART (Y4); HIV-infected MSM with
AIDS-related mortality; and HIV-infected MSM who emigrated
from the sexually active MSM community or have non-AIDS
mortality.[13] Since the last two groups did not affect changes of
MSM population in the other groups, our model included five
differential equations describing the dynamics of the five groups
(X, Y1, Y2, Y3, and Y4). The developed model was adapted from
Clements et al,[3] where the compartments were subject to
diagnosis and treatment. Since viral load is a critical factor for
HIV transmission or infection rate, and ART can reduce and
maintain low viral loads, we considered this in the model.
Specifically, among the treated patients, 70% were considered to
be successful in the suppression of viral loads and the rest were
considered to have failed.[14] This is reflected in our model by
splitting the treated group into two separate compartments of
treatment failure (Y3) and successful treatment.(Y4) In addition, the
PrEP efficacy parameter, fp, was included in the model because
ART for non-HIV infected MSM group could reduce the
incidence of HIV infection.
The current study is based on derivative values, which are
distributed in ranges but are not numerical. Table 1 shows the
derivative values for each of the variables, parameters and
references (see Table S1 for more details). The values were
decided by the best available local epidemiological data, literature
reviews, investigator’s derivations, and calculations based on
mathematical formulas. Some parameters (number of uninfected
MSM [X]; number of undiagnosed, infected MSM [Y1];number
of diagnosed; infected MSM without treatment [Y2]; number of
infected MSM with treatment failure [Y3]; number of infected
MSM with successful treatment [Y4]; proportion of successful
treatments [s];rate of decline for undiagnosed [h1];and rate of
decline for diagnosed [h2]) were decided based on the best
available local epidemiological data. The best available local
epidemiological data described the authenticity as demonstrated
by references cited in the text. Some parameters (the number of
new uninfected homosexual men each year [nx]; diagnosis rate
[v1]; treatment uptake rate [v2]; and rate of AIDS death for
infected MSM after treatment failure[h3]) were derived from the
previous studies.[4,15–19] nx was decided as 2,100 to 4,500
persons, derived from the finding that the annual proportion of
new uninfected MSM would be 3% among the whole MSM
population (70,000 to 150,000 persons).[4] v1 was computed as
0.1667 for those not diagnosed at seroconversion, derived from the
finding that new HIV-infected men would be diagnosed in 5,7
years on average.[15,16] v2 was computed as 1.4794, derived from
the finding that 95% of HIV-diagnosed men would start ART in
2.025 years on average.[18] In terms of proportion of ART use
among MSM, 95% ART use within one year of diagnosis was
selected as a possible maximal value that could be achieved in the
real world. Values for the other parameters were taken by
referring to the previous studies shown in Table 1 and Table
S1.[3,14,17,20–26]
The preventive interventions of interests were: early diagnosis,
early ART, and PrEP. Because some reports had concerns, such as
interventions could affect the level of risky sexual behaviors,
[27,28] the model considered the relationship between the
interventions and the level of unprotected anal intercourse. New
HIV infections in uninfected MSM were modeled based on the
average number of HIV-infected partners with whom the MSM
would have unprotected anal intercourse (UAIC), and the average
possibility of HIV transmission occurring with that partner
(infectiousness). The investigator derived that the HIV diagnosis
could reduce the level of UAIC between uninfected men and HIV-
diagnosed men up to 50% (fd= 0.5), and the successful ART could
reduce the infectiousness up to 96% (fts=0.04).[3] Referring to a
previous study,[3] the proportion of new HIV infections undiag-
nosed at seroconversion (a) was derived as 50%. Through this
procedure, the rest of parameters, including the HIV infection rate
for uninfected MSM (K), undiagnosed (K1), diagnosed (K2),
treatment failure (K3), and successful treatment (K4) were
calculated by the transmission equations. The annual number of
men within each group and the annual number of newly infected
MSM (KX) were computed by simulating the mathematical model
by assigning values to the parameters and initial states. (Fig. 1 and
Fig. S1)
Interventions scenarios
To mirror the uncertainty in many of factors included in our
model, a simulation approach was introduced. We assumed five
scenarios:
Scenario 1: 95% of HIV-diagnosed MSM take ART within 1
year of diagnosis.
Scenario 2: HIV-infected MSM know their disease within 1
year of infection.
Scenario 3: PrEP decreased HIV infectivity by 44%, while
unsafe sex behavior did not increase.
Scenario 4-1: PreP decreased HIV infectivity by 44%, and
unsafe sex behavior increased by 10%.
Scenario 4-2: PreP decreased HIV infectivity by 44%, and
unsafe sex behavior increased by 20%.
Scenario 4-3: PreP decreased HIV infectivity by 44%, and
unsafe sex behavior increased by 30%.
Scenario 5: Combined the following factors: HIV-infected
MSM would be diagnosed within 1 year of infection, 99% of HIV-
diagnosed MSM take ART within 1 year of diagnosis, and PrEP
Mathematical Modeling on HIV in South Korea
PLOS ONE | www.plosone.org 2 March 2014 | Volume 9 | Issue 3 | e90080
decreased HIV infectivity by 44% while unsafe sex behavior did
not increase at all.
We estimated the effects of each these scenarios on the HIV
incidence (KX) and prevalence (Y1 to Y4) over the next 40 years,
as compared to the current situation which was defined as future
epidemic that would be expected without any new prevention
measures.
Outcomes involving uncertainty
Among the various outcomes, ‘‘KX’’ and ‘‘Y1 to Y4’’ were
selected to evaluate the time trend of HIV incidence and
prevalence, respectively. The number of newly infected MSM is
meant to be KX. The number of current HIV infected MSM
regardless of diagnosis or treatment is meant to be Y1 to Y4. The
outcomes were examined up to 40 years after each intervention
considering the increasing life expectancy of HIV-infected persons.
To reflect the uncertainty of parameters, simple random sampling
with uniform distributions between 6 10% of baseline of all
parameters were assumed. In Fig. 2, 1000 simulations are plotted
using boxplots for time-dependent uncertainty analysis. Effective-
ness of interventions was predicted in terms of the ratio of incident
HIV cases prevented (Fig. 2A) and the ratio of prevalent HIV
cases avoided (Fig. 2B). In other words, the plots above zero
illustrate that ratio of HIV cases decreased as compared to the
current situation and the plots below zero show that ratio of HIV
cases increased. To assess the effect of the level of unsafe sex
(UAIC) in PrEP, we compared the number of prevalent HIV cases
with scenario 3 and 4-1, 4-2, 4-3 to current situation in Fig. 3.
Moreover, as well as the value by plotted using boxplots, the
median values of KX and Y1–4 in each scenario were shown on
Table S2.
Sensitivity analysis
The presence of parameters (including the initial values), none
of which are known with confidence, makes a comparison of the
various intervention strategies difficult. To observe the effect of
uncertainty in parameters on outcomes, sensitivity analysis was
performed. A picture of the elasticity of outcomes with respect to
the parameters is given in Fig. 4. To generate Fig. 4, 1000 sets of
parameter values were randomly sampled from uniform distribu-
tions between the limits of 610% of baseline. Fig. 4-A and 4-B
show boxplots of the elasticities of the number of incident (KX)
and prevalent (Y1–4) HIV cases to each parameter. A boxplot is a
graphical representation of the quartiles of a data set in which the
box contains the median value of the data, and extends from the
first to the third quartile. The elasticity of KX with respect to a
parameter W is defined as:
LKX
KX

LW
W
.
Results
Current situation
We defined the ‘current situation’ in South Korea as one where
an epidemic could be expected to occur in the future if new
prevention measures are not undertaken. Our predictions are
based on a mathematical simulation, which suggested that the
number of incident HIV cases would increase from 3262.5 to
8469.1 in the first 10 years, but start to fall to 5944.5 in the next 15
years, and fall to 2610.4 in 40 years. The simulation also indicated
that the number of prevalent HIV cases would increase from 8713
to 60465.5 in the first 15 years, fall to 58319.6 in the next 20 years,
and fall to 37651.6 in 40 years. According to our predictions, the
HIV incidence rate among the MSM population in South Korea
will range between 0.01% and 0.03% in the first 5 years, and the
Figure 1. Multistate HIV infection model for a MSM population. NOTE: See table 1 and S1 for referring the meaning of each abbreviations
doi:10.1371/journal.pone.0090080.g001
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Table 1. Variables and parameters for model.
Variables/
Parameters Meaning Value Unit References
X number of uninfected MSM 133077 number [25]
Y1 number of undiagnosed, infected MSM 3438 number [25]
Y2 number of diagnosed, infected MSM without treatment 1213 number [1]
Y3 number of infected MSM with treatment failure 1219 number [14]
Y4 number of infected MSM with successful treatment 2843 number [14]
nx number of new uninfected MSM each year 3300 number/year Derivation
a proportion of new infections undiagnosed at seroconversion 0.5 dimensionless [3]
v1 diagnosis rate 0.1667 1/year Derivation
v2 treatment uptake rate 1.4794 1/year Derivation
s proportion of successful treatments 0.8816 dimensionless [14]
u3 treatment cessation rate due to treatment failure 0.3 1/year [20]
u4 treatment cessation rate due to successful treatment 0.15 1/year [20]
v3 treatment success rate 0.3542 1/year [21,23]
w4 treatment relapse rate 0.235 1/year [26]
h1 rate of AIDS death for undiagnosed and diagnosed MSM 1/10 [22]
h2 rate of AIDS death for undiagnosed and diagnosed MSM 1/10 1/year [22]
h3 rate of AIDS death for infected MSM after treatment failure 1/17 1/year Derivation
h4 rate of AIDS death for infected MSM after successful treatment 1/32 1/year [17,24]
g background migration rate for MSM 1/33.3 1/year [3]
bc average probability of HIV transmission occurring to a partner
(infectiousness) * average annual number of HIV-infected partners
with whom uninfected men have unprotected anal intercourse
0.8 1/year [4]
fu increased level of UAIC 1.1 dimensionless [3]
fd effect of diagnosis on reducing the rate of UAIC between
uninfected and diagnosed men
0.5 dimensionless [3]
ftf average decrease in infectiousness as a result of treatment failure 0.4 dimensionless [9]
fts average decrease in infectiousness as a result of successful
treatment
0.04 dimensionless [9]
fp average decrease in infectiousness as a result of PrEP 0.56 dimensionless [10]
K HIV infection rate for uninfected MSM
K~
P
i~1
4KYi
Xz
P
i~1
4Yi
1/year Calculation
by
transmission
equations
K1 HIV infection rate for infected, undiagnosed MSM fpfubc 1/year Calculation
by
transmission
equations
K2 HIV infection rate for infected, diagnosed MSM fpfufdbc 1/year Calculation
by
transmission
equations
K3 HIV infection rate for infected MSM with treatment failure fpfufd ftf bc 1/year Calculation
by
transmission
equations
K4 HIV infection rate for infected MSM with successful treatment fpfufd ftsbc 1/year Calculation
by
transmission
equations
NOTE. MSM, men who sex with men; UAIC, unprotected anal intercourse.
Value of variables (X, Y1, Y2, Y3, Y4) meant to be initial value for mathematical model. Value of parameters (from nx to fp) meant to be current value for model.
a, s, v3, and v4 are calculated by following equation: If there z% in t years, then the yearly rate r was computed by r~{ ln 1{z=100ð Þ=t.
v1, v2, h1, h2, h3, and h4 are calculated by following equation: If it takes t years on average to move to the next compartment, then the yearly rate r was computed by
r~1=t.
K,K1,K2,K3,K4 are calculated by transmission equations supplemented by Fig. S1.
Dimensionless: it has no unit, such as a ratio or a percentage.
doi:10.1371/journal.pone.0090080.t001
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HIV prevalence rate among the MSM population in South Korea
will range between 0.03% and 0.11% in the same time frame.
Early ART (Scenario 1)
If 95% of HIV-diagnosed MSM take ART within 1 year of
diagnosis, the number of incident HIV cases would be reduced by
13% compared to the current situation in the first 10 years, but
ultimately it would be similar to the current situation at 40 years
(Fig. 2A-1). Similarly, the number of prevalent HIV cases would
be reduced only by 3% compared to the current situation in the
first 20 years (Fig. 2B-1).
Figure 2. Modeled HIV incidence under different scenarios. A-1. Ratio of incident HIV cases (KX) compared early ART (scenario 1) with current
situation. A-2. Ratio of incident HIV cases (KX) compared early diagnosis (scenario 2) with current situation. A-3. Ratio of incident HIV cases (KX)
compared PrEP (scenario 3) with current situation. A-4. Ratio of incident HIV cases (KX) compared all interventions (scenario 5) with current situation.
B-1. Ratio of prevalent HIV cases (Y1–4) compared early ART (scenario 1) with current situation B-2. Ratio of prevalent HIV cases (Y1–4) compared early
diagnosis (scenario 2) with current situation. B-3. Ratio of prevalent HIV cases (Y1–4) compared PrEP (scenario 3) with current situation. B-4. Ratio of
prevalent HIV cases (Y1–4) compared all interventions (scenario 5) with current situation. NOTE: The boxplot contains the median value of the data
(horizontal red line), and extends from the first to the third quartile when simple random sampling with uniform distributions between 610% of
baseline of all parameters are used. Whisker bars are extended to minimum and maximum. Figures are the simulations of scenarios 1, 2, and 3, and 5.
The X-axis represented the time sequence from initial to 40 years, and the Y-axis represented the ratio of HIV incidence (KX) and prevalence (Y1–4)
compared with current status. Plots over zero represented a decrease over HIV incidence and prevalence than the current situation, while plots under
zero meant an increase in HIV incidence and prevalence over current situation.
doi:10.1371/journal.pone.0090080.g002
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Early diagnosis (Scenario 2)
If HIV-infected individuals were diagnosed with HIV infection
within the first year of infection (scenario 2), the number of
incident HIV cases would be reduced by 71% in the first 10 years.
It would be reduced by 23% in the next 20 years, and the number
of incident HIV cases would be similar to the current figure at 40
years (Fig. 2A-2, Table S2). With early diagnosis, the number of
prevalent HIV cases would be reduced by 61% in the first 15 years
and 40% in the next 25 years, and the number of prevalent HIV
cases would be similar to the current figure at 40 years (Fig. 2B-2,
Table S2). Despite the uncertainty of the parameters, the
preventive effects of early diagnosis were somehow certain before
20 years because most of the boxplots were above zero. The
reliability of the preventive effects of an early diagnosis seemed to
decrease after 20 years.
PrEP (Scenarios 3) and the effect of unsafe sexual
behavior (Scenario 4)
Based on previous studies in MSM, the effectiveness of PrEP
was deemed to be 44% in the model simulations [10]. We also
modeled the effectiveness of PrEP based on changes in sexual risk.
When there was no increase in unsafe sexual behavior (Scenario
3), the number of incident HIV cases would be reduced by 75% in
the first 5 years and 77% in the next 10 years. It would be reduced
by 66% in 15 years, 28% in 25 years, and 20% in 40 years as
compared to the current situation (Fig. 2A-3, Table S2). Similarly,
the number of prevalent HIV cases would be reduced by 69% in
the first 10 years and 37% at 40 years as compared to the current
situation (Fig. 2B-3, Table S2). Similar to early diagnosis, the
preventive effects of PrEP were certain before 20 years because
most boxplots were above zero. However, the reliability of
preventive effects of an early diagnosis seemed to decrease after
20 years.
We then evaluated PrEP when its effectiveness was reduced by
an increase in unsafe sex practices (Fig. 3, Table S2). When the
effectiveness of PrEP was reduced by a 10% increase in unsafe sex
behavior, the number of incident HIV cases would be reduced by
69% in the first 5 years as compared to the current situation and
by 26% in the next 20 years as compared to the current situation
(Fig. 3A, Table S2). Similarly, the number of prevalent HIV cases
would be reduced by 63% in the first 10 years and by 20% in 40
years as compared to the current situation (Fig. 3B, Table S2).
When the effectiveness of PrEP was reduced by a 20% increase in
unsafe sexual practices, the number of incident HIV cases would
be reduced by 62% in 10 years but was similar to the current
situation in 40 years (Fig. 3A, Table S2). The number of prevalent
HIV cases would be reduced by 56% in the first 10 years but only
by 10% in 40 years as compared to the current situation (Fig. 3B,
Table S2). When the effectiveness of PrEP was decreased by a
30% increase in unsafe sex behavior, the number of incident HIV
cases would be reduced by 52% in 10 years, but it was similar to
the current situation in 40 years (Fig. 3A, Table S2). The number
of prevalent HIV cases would be reduced by 49% in the first 10
years but only by 4% in 40 years as compared to the current
situation (Fig. 3B, Table S2). Accordingly, our scenario showed
that PrEP would be more effective in reducing HIV transmission
over the next 15 years compared to the current situation. Although
the potential reduction could be counterbalanced by unsafe sex,
this would not be sufficient to negate the improvement completely.
Combination interventions (Scenario 5)
If the interventions were combined to evaluate the maximal
effect, the incidence of HIV would decrease sharply from 1827 to
Figure 3. Comparison of number of incident HIV cases (KX) and prevalent HIV cases (Y1–4) between current situation and efficacy of
PrEP modulated by unsafe sex practices (scenario 3 to 4-1,4-2, and 4-3). A. Comparison of number of incident HIV cases (KX) between
current situation and scenarios 3 to 4-1, 4-2, and 4-3. B. Comparison of number of prevalent HIV cases (Y1–4) between current situation and efficacy of
PrEP modulated by unsafe sex practices (scenario 3 to 4-1, 4-2, and 4-3). NOTE: Stream of current status, scenarios 3. 4-1, 4-2, and 4-3. Figure 3A: X-axis
represented time sequence from now to 40 years and Y-axis represented stream of number of incident HIV cases (KX) compared to current situation
with PrEP scenarios 3 to 4-1,4-2,4-3. Figure 3B: X-axis represented time sequence from now to 40 years, and Y-axis represented the number of
prevalent HIV cases (Y1 to Y4) comparing current situation with PrEP scenarios 3, 4-1, 4-2, and 4-3.
doi:10.1371/journal.pone.0090080.g003
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408.4 cases in the first 5 years and to 166.8 cases in 40 years. The
incidence would be reduced by 94.4% in the first 5 years and
93.7% in 40 years as compared to the current situation (Fig 3A-4,
Table S2). Further, the number of prevalent HIV cases would
continue to fall from 8712 to 3483.8 through 40 years. Overall, the
HIV prevalence would be reduced by 68% in 5 years and 90.8%
in 40 years as compared to the current situation (Fig. 3B-4, Table
S2).
Sensitivity analysis
To determine which factors and terms had the greatest effect on
estimating HIV prevalence and incidence, we performed a
sensitivity analysis. It provides a way to illustrate the effects of
Figure 4. Sensitivity analysis for the number of incident HIV cases (KX) and the number of prevalent HIV cases (Y1–4). A-1. Averaged
sensitivities in magnitudes of the number of incident HIV cases (KX) per year to each parameter. A-2. Sensitivities of the number of incident HIV cases
(KX) per year to each parameter at 10 year. B-1. Averaged sensitivities in magnitudes of the number of prevalent HIV cases (Y1–4) per year to each
parameter. B-2. Sensitivities of the number of prevalent HIV cases (Y1–4) per year to each parameter at 10 year. NOTE: The elasticity of KX with respect
to a parameter W is defined as: LKX
KX

LW
W . The X-axis of Figures A and B represents the elasticity of incident (KX) and prevalent (Y1–4) HIV cases,
respectively. See table 1 and S1 for referring the meaning of each abbreviations within Y-axis. Figures 4A-1 and 4B-1 show the average elasticities of
outcomes over 40 years and Figures 4A-2 and 4B-2 show the elasticities of outcomes at the time point of 10 years. The boxplot contains the median
value (horizontal red line), and extends from the first to the third quartile when simple random sampling with uniform distributions between 610%
of baseline of all parameters are used. Whisker bars are extended to minimum and maximum.
doi:10.1371/journal.pone.0090080.g004
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parameters on outcomes using derivative values of outcomes with
respect to parameters. The derivatives in the sensitivity analysis
were approximated by percent changes in outcomes with percent
change in the parameter value. Since these sensitivities are time
dependent, averaged magnitudes of incident HIV cases over time
and at 10 year are displayed in Fig. 4A-1 and Fig. 4A-2,
respectively. Computations were repeated for each of the 1000
parameter sets, giving the results of prevalent HIV cases Y1–4 per
year, displayed in Fig. 4B-1 and Fig. 4B-2. While the averaged
sensitivities and at 10 year were not identical, some general
statements can be made. In Fig. 4A and Fig. 4B, outcomes are
more robust to the changes in parameters if the values are closer
the horizontal axis. For example, in the absence of an intervention
strategy (i.e. current situation), outcomes were most sensitive to
transmission rate (bc) because the values were located furthest
from zero. Similarly, when considering an intervention, transmis-
sion rate (bc), the level of UAIC (fu), and the average decrease in
infectiousness as a result of PrEP (fp) had the most crucial effect on
outcomes. We observed that some of the parameters, such as
treatment cessation rate due to treatment failure (u3) and initial
values of the number of infected MSM who are diagnosed
regardless of treatment (Y2, Y3,Y4), had little effect on HIV
prevalence because the values were located quite close to zero with
these parameters.
Discussion
HIV remains one of the world’s most challenging public health
threats, and if we are going to stem the current epidemic, then we
must evaluate every tool possible. One way to evaluate potential
prevention measures before their implementation is through the
use of mathematical models, as conducted here. Since in South
Korea the most common mode of HIV transmission has gradually
changed from heterosexual to homosexual contact among men,[1]
we evaluated the use of a variety of prevention interventions, as
compared to the estimated current situation. Since there are no
pertinent data available from the epidemic over the past 10–20
years in South Korea, we only used data available to the current
situation where the number of HIV incident cases among MSM
would increase from 3262.5 to 7166.3 persons in the first 5 years.
This trend is quite reasonable because approximately half of HIV-
infected persons are currently ‘late presenters’ and many infected
persons are still undiagnosed in South Korea. [15] Even though
the HIV incidence rate among MSM in South Korea has varied
from 0.01% to 0.03% in the first 5 years of our predictions, it
would be still much lower than that of China [29] and Japan.[30]
Further, the prevalence of HIV infection among MSM in Japan
has been estimated at about 2% based on probability samples,[30]
and another Japanese study showed that the HIV prevalence
would climb from its current rate of 2.1% to 10.4% without new
interventions amongst MSM in Japan.[31] Interestingly, the
incidence and prevalence of HIV infection among MSM in South
Korea was estimated to be low comparing with neighboring
nations. Therefore, we feel that the predicted rapid increase of
HIV incident and prevalent cases are reasonable estimates.
Recently, the HIV prevention field has witnessed the first
clinical success with oral and topical PrEP in stopping the sexual
transmission of HIV-1,[32,33] and as a result of this successful
trial, the US FDA approved the use of PrEP with the combination
drug of tenofovir disoproxil fumarate and emtricitabine. Some
previous mathematical modeling studies have reported the effect of
ART for HIV-infected individuals on HIV incidence,[3–5] but
there has been no study regarding modeling the effects of PrEP on
HIV incidence. Based on the realistic and available data, our
mathematical model suggests that PrEP using the combination
drug of tenofovir disoproxil fumarate and emtricitabine would
decrease HIV incidence among MSM in South Korea. PrEP
without increased unsafe sex behavior reduced the HIV incidence
by 77% in comparison with current status. Interestingly, even
though the usefulness of PrEP could be limited by increased unsafe
sex behavior, PrEP still demonstrated a more beneficial effect in
HIV incidence than the current situation. The effectiveness of
PrEP was still large even when considering an increase in risky
behavior by 30%. Interestingly, the use of ART within one year of
diagnosis showed very little impact to incidence as compared to
the current situation, while diagnosis within one year of infection
showed a comparable decrease in incidence as compared to PrEP.
In other words, PrEP reduced the HIV incidence by 74%
comparing with the use of ART within one year of diagnosis just in
10 years. Moreover, PrEP reduced the HIV incidence by 23%
comparing with diagnosis within one year of infection. For our
simulations, 95% ART use within one year of diagnosis was
selected as the best possible value, but the predictions of HIV
incident and prevalent cases through simulation were not much
different between 95% or 100% ART use.
In the present study, we did not consider cost-effectiveness of
each intervention because we are interested in the change of the
incidence or prevalence of HIV after implementation of each
intervention. This is especially pertinent, since PrEP is relatively
expensive and could be cost prohibitive for public policy
implementation.[34] For example, it is unclear from the modeling
whether it would be more cost effective to provide PrEP or to
increase early diagnosis among MSM. Nevertheless, if the society
could bear medical expenses of all possible interventions, the best
way to reduce HIV incidence is scenario 5, which includes
diagnosing the disease within one year of infection, treating almost
all (approximately 99%) the HIV infected persons within one year
of diagnosis, taking PrEP and unchanged unsafe sex behavior. In
scenario 5, the HIV incidence sharply decreased in 5 years and
kept low level for the modeled 40 years of observation. Our
mathematical model is optimized for the HIV transmission among
MSM in South Korea and cannot reflect all the possible
complexities of other epidemics. To overcome these limitations,
we utilized the best available epidemiological data as much as
possible. Nevertheless, data on some parameters were obtained
from previous studies conducted in other countries, including the
number of new uninfected MSM each year (nx), the proportion of
new infections undiagnosed at seroconversion (a), the treatment
cessation rate due to treatment failure (u3) and successful treatment
(u4), the treatment success rate (v3), the treatment relapse rate (w4),
and the rate of AIDS death for infected MSM after successful
treatment (h4).
Thus, generalization of our results to other populations might
be limited and our estimates might also be biased because of
including parameter estimates from western countries, as with
most mathematical models. These data from other countries could
influence the conclusions of our study. Additionally, our deriva-
tions of parameters including diagnosis rate (v1), treatment uptake
rate (v2), and rate of AIDS death for infected MSM after treatment
failure (h3) was not validated, even though they were based on best
available epidemiologic data. Considering these limitations and
the uncertainties, we chose a simulation approach, permitting
many parameters to vary over a range of uncertainty; however,
predictions from our models also depended upon the presented
derivations and should be interpreted cautiously.
In spite of these limitations, our study has provided a number of
unique insights, which should be evaluated in clinical studies to
assess real-life viability. Based on these modeling estimates, we feel
Mathematical Modeling on HIV in South Korea
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that such clinical studies should compare the use of PrEP and early
diagnosis versus a combined approach among MSM to reduce
HIV incidence. Moreover, these clinical efficacy studies should
include a component of cost effectiveness to fully evaluate public
health feasibility and societal cost.
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